Richard L. Eberly Net Worth

The estimated Net Worth of Richard Eberly is at least $1.05 Million dollars as of 15 March 2022. Mr Eberly owns over 377,145 units of Chembio Diagnostics stock worth over $124,123 and over the last 21 years he sold CEMI stock worth over $374,126. In addition, he makes $556,033 as Pres and CEO & Director at Chembio Diagnostics.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr Eberly CEMI stock SEC Form 4 insiders trading

Mr has made over 7 trades of the Chembio Diagnostics stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 377,145 units of CEMI stock worth $173,487 on 15 March 2022.

The largest trade he's ever made was exercising 377,145 units of Chembio Diagnostics stock on 15 March 2022 worth over $173,487. On average, Mr trades about 11,241 units every 75 days since 2003. As of 15 March 2022 he still owns at least 269,833 units of Chembio Diagnostics stock.

You can see the complete history of Mr Eberly stock trades at the bottom of the page.

Mr. Richard L. Eberly biography

Richard L. Eberly is the Pres, CEO & Director at Chembio Diagnostics.

What is the salary of Mr Eberly?

As the Pres and CEO & Director of Chembio Diagnostics, the total compensation of Mr Eberly at Chembio Diagnostics is $556,033. There are 1 executives at Chembio Diagnostics getting paid more, with Javan Esfandiari having the highest compensation of $557,521.

How old is Mr Eberly?

Mr Eberly is 60, he's been the Pres and CEO & Director of Chembio Diagnostics since . There are 3 older and 4 younger executives at Chembio Diagnostics. The oldest executive at Chembio Diagnostics Inc. is Mary Polan, 76, who is the Independent Director.

What's Mr Eberly's mailing address?

Richard's mailing address filed with the SEC is C/O CHEMBIO DIAGNOSTICS, INC., 3661 HORSEBLOCK ROAD, MEDFORD, NY, 11763.

Insiders trading at Chembio Diagnostics

Over the last 20 years, insiders at Chembio Diagnostics have traded over $909,824 worth of Chembio Diagnostics stock and bought 3,754,893 units worth $1,696,058 . The most active insiders traders include Credit Advisors, Llcpercept..., Lawrence A. Siebert, and Richard Eberly. On average, Chembio Diagnostics executives and independent directors trade stock every 90 days with the average trade being worth of $36,203. The most recent stock trade was executed by Credit Advisors, Llcpercept... on 21 April 2023, trading 243,448 units of CEMI stock currently worth $109,552.

What does Chembio Diagnostics do?

Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.

Complete history of Mr Eberly stock trades at Chembio Diagnostics and Meridian Bioscience

Chembio Diagnostics executives and stock owners

Chembio Diagnostics executives and other stock owners filed with the SEC include:

• Javan Esfandiari,
  Exec. VP and Chief Science & Technology Officer
• Richard L. Eberly,
  Pres, CEO & Director
• Javan Esfandiari,
  Executive Vice President, Chief Scientific And Technology Officer
• Neil Goldman,
  Chief Financial Officer, Executive Vice President
• Katherine Davis,
  Independent Director
• John Potthoff,
  Independent Director
• Gail Page,
  Executive Chairman of the Board
• Mary Polan,
  Independent Director
• Lynn Lewis,
  Investor Relations Contact Officer
• Chuck Caso,
  Vice President of Sales and Marketing for North America
• Richard Eberly,
  President, Chief Executive Officer, Director
• Stella Rivera,
  VP of HR
• Atif Rizvi,
  VP of Fin.
• Dr. Konstantin Lyashchenko,
  Research Director of Chembio Diagnostic Systems Inc
• Charles Caso,
  VP of Sales & Marketing
• Paul J. Angelico,
  VP of Global Operations
• Peter Kissinger,
  Director
• Richard J Larkin,
  Chief Financial Officer
• Barbara A De Buono,
  Director
• John J Iii Sperzel,
  CEO
• Robert L Aromando,
  Sr VP, Commercial Operations
• Alan Carus,
  Director
• Lawrence A. Siebert,
  President
• Leslie Teso Lichtman,
  
• Norman H Pessin Brian L. Pe...,
  
• Gary Meller,
  Director
• Sharon W Klugewicz,
  Chief Operating Officer
• David Gyorke,
  See Remarks
• Robert Passas,
  See Remarks
• Avi Pelossof,
  Vice President
• Gerald A Eppner,
  Director
• James D Merselis,
  Director
• Capital Master Llc Crestvie...,
  
• David Acheson,
  
• Credit Advisors, Llcpercept...,
  
• David William Bespalko,
  
• Lawrence J. Steenvoorden,
  See remarks
• Charles Caso,
  See Remarks
• Paul Angelico,
  See remarks